Orthofix Medical Inc. (OFIX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $4.07M; Additional Paid in Capital, Common StockUSD $830.42M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-277.00K; Retained Earnings (Accumulated Deficit)USD $-405.04M.
- 2026-03-31: Common Stock, Value, IssuedUSD $4.04M; Additional Paid in Capital, Common StockUSD $820.25M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $142.00K; Retained Earnings (Accumulated Deficit)USD $-389.24M.
- 2025-12-31: Common Stock, Value, IssuedUSD $3.98M; Additional Paid in Capital, Common StockUSD $813.77M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $618.00K; Retained Earnings (Accumulated Deficit)USD $-368.33M.
- 2025-09-30: Common Stock, Value, IssuedUSD $3.95M; Additional Paid in Capital, Common StockUSD $804.01M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $634.00K; Retained Earnings (Accumulated Deficit)USD $-366.11M.
Orthofix Medical Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Common Stock, Value, Outstanding USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Adjustments to Additional Paid in Capital, Reallocation of Noncontrolling Interest (Deprecated 2013-01-31) USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.07M | $830.42M | $-277.00K | $-405.04M | $429.18M | 3 month · $7.74M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $4.04M | $820.25M | $142.00K | $-389.24M | $435.19M | 3 month · $6.53M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $3.98M | $813.77M | $618.00K | $-368.33M | $450.04M | 12 month · $28.69M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $3.95M | $804.01M | $634.00K | $-366.11M | $442.49M | 3 month · $7.18M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $3.95M | $796.81M | $908.00K | $-343.32M | $458.35M | 3 month · $7.82M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $3.91M | $786.17M | $-2.56M | $-329.24M | $458.29M | 3 month · $6.47M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $3.85M | $779.72M | $-4.30M | $-276.14M | $503.12M | 12 month · $32.45M | (m) | (m) | (m) | (m) |
| 2024-09-30 | $3.82M | $770.00M | $-902.00K | $-247.00M | $525.92M | 3 month · $6.53M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $3.80M | $764.54M | $-2.73M | $-219.61M | $546.00M | 3 month · $9.96M | (m) | (m) | (m) | (m) |
| 2024-03-31 | $3.74M | $753.40M | $-660.00K | $-186.16M | $570.32M | 3 month · $8.80M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $3.72M | $746.45M | $-1.29M | $-150.14M | $598.73M | 12 month · $35.71M | (m) | (m) | (m) | (m) |
| 2023-09-30 | $3.67M | $741.64M | $-1.86M | $-127.97M | $615.48M | 3 month · $6.27M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $3.67M | $735.53M | $-108.00K | $-99.11M | $639.99M | 3 month · $13.25M | (m) | (m) | (m) | (m) |
| 2023-03-31 | $3.65M | $721.14M | $-946.00K | $-59.69M | $664.16M | 3 month · $13.02M | (m) | (m) | (m) | (m) |
| 2022-12-31 | $2.02M | $334.97M | $-1.38M | $1.25M | $336.86M | 12 month · $18.44M | (m) | (m) | (m) | (m) |
| 2022-09-30 | $2.00M | $328.39M | $-5.16M | $8.31M | $333.54M | 3 month · $4.73M | (m) | (m) | (m) | (m) |
| 2022-06-30 | $2.00M | $323.74M | $-2.82M | $19.03M | $341.95M | 3 month · $4.46M | (m) | (m) | (m) | (m) |
| 2022-03-31 | $1.98M | $318.21M | $-1.16M | $16.54M | $335.57M | 3 month · $4.33M | (m) | (m) | (m) | (m) |
| 2021-12-31 | $1.98M | $313.95M | (m) | $21.00M | $336.93M | 12 month · $15.43M | (m) | (m) | (m) | (m) |
| 2021-09-30 | $1.97M | $307.78M | $1.26M | $53.81M | $364.83M | 3 month · $3.84M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $1.97M | $302.74M | $1.60M | $55.98M | $362.28M | 3 month · $3.91M | (m) | (m) | (m) | (m) |
| 2021-03-31 | $1.95M | $297.63M | $1.68M | $53.56M | $354.82M | 3 month · $3.72M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.94M | $292.29M | $3.25M | $59.38M | $356.86M | 12 month · $16.21M | (m) | (m) | (m) | (m) |
| 2020-09-30 | $1.93M | $285.20M | $-991.00K | $68.76M | $354.90M | 3 month · $3.84M | (m) | (m) | (m) | (m) |
| 2020-06-30 | $1.92M | $282.29M | $-3.27M | $64.10M | $345.05M | 3 month · $4.70M | (m) | (m) | (m) | (m) |
| 2020-03-31 | $1.91M | $275.69M | $-4.75M | $82.53M | $355.37M | 3 month · $3.86M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $1.90M | $271.02M | $-3.04M | $57.75M | $327.63M | 12 month · $21.54M | (m) | (m) | (m) | (m) |
| 2019-09-30 | $1.89M | $263.06M | $-4.58M | $46.06M | $306.43M | 3 month · $5.84M | (m) | (m) | (m) | (m) |
| 2019-06-30 | $1.88M | $257.89M | $1.46M | $86.56M | $347.79M | 3 month · $5.85M | (m) | (m) | (m) | (m) |
| 2019-03-31 | $1.88M | $252.86M | $1.83M | $87.11M | $343.68M | 3 month · $5.68M | (m) | (m) | (m) | (m) |
| 2018-12-31 | $1.86M | $243.16M | $3.30M | $87.08M | $335.40M | 12 month · $18.93M | (m) | (m) | (m) | (m) |
| 2018-09-30 | $1.85M | $238.42M | $4.87M | $78.21M | $323.35M | 3 month · $5.26M | (m) | (m) | (m) | (m) |
| 2018-06-30 | $1.85M | $233.74M | $4.84M | $79.42M | $319.85M | 3 month · $5.21M | (m) | (m) | (m) | (m) |
| 2018-03-31 | $1.84M | $228.36M | $4.48M | $78.49M | $313.17M | 3 month · $3.92M | (m) | (m) | (m) | (m) |
| 2017-12-31 | $1.83M | $220.59M | $3.79M | $70.40M | $296.61M | 12 month · $12.56M | (m) | (m) | (m) | (m) |
| 2017-09-30 | $1.82M | $215.78M | $-1.12M | $68.83M | $285.31M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $1.81M | $211.99M | $-2.23M | $65.38M | $276.95M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $1.80M | $208.69M | $-4.88M | $61.52M | $267.13M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $1.78M | $204.09M | $-6.58M | $64.18M | $263.48M | 12 month · $15.97M | (m) | (m) | (m) | (m) |
| 2016-09-30 | $1.80M | $208.11M | $-4.15M | $67.42M | $273.18M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $1.81M | $205.34M | $-7.97M | $59.06M | $258.23M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $1.82M | $212.72M | $-5.51M | $66.44M | $275.47M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $1.87M | $232.13M | $-6.23M | $62.55M | $290.31M | 12 month · $7.21M | (m) | (m) | (m) | (m) |
| 2015-09-30 | $1.89M | $239.95M | $-3.82M | $59.18M | $297.21M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $1.88M | $237.99M | $-2.75M | $60.55M | $297.68M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $1.88M | $236.26M | $-4.58M | $56.98M | $290.54M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $1.86M | $232.79M | $-382.00K | $65.36M | $299.63M | 12 month · $5.72M | (m) | (m) | (m) | (m) |
| 2014-09-30 | $1.86M | $231.04M | $959.00K | $71.16M | $305.02M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $1.85M | $228.50M | $4.15M | $70.71M | $305.21M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $1.84M | $223.36M | $3.98M | $71.39M | $300.56M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $1.81M | $216.65M | $3.50M | $73.90M | $295.86M | 12 month · $6.27M | (m) | (m) | (m) | (m) |
| 2013-09-30 | $1.81M | $215.08M | $4.96M | $97.21M | $306.99M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $1.85M | $225.15M | $1.20M | $117.03M | $332.15M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $1.95M | $250.38M | $1.72M | $119.35M | $360.98M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $1.93M | $246.31M | $5.49M | $102.71M | $356.44M | 12 month · $6.30M | (m) | (m) | (m) | (m) |
| 2012-09-30 | $1.93M | $246.05M | $1.59M | $128.03M | $332.42M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $1.90M | $231.76M | $88.00K | $120.47M | $312.92M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $1.87M | $222.79M | $4.47M | $109.27M | $298.55M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $1.85M | $214.50M | $3.71M | $72.01M | $280.30M | 12 month · $6.65M | $280.30M | 12 month · $517.00K | 12 month · $1.74M | 12 month · $-517.00K |
| 2011-09-30 | $1.84M | $220.64M | $3.60M | $84.86M | $292.09M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $1.82M | $213.29M | $10.31M | $72.48M | $279.98M | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | $263.99M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $1.77M | $195.40M | $5.39M | $98.33M | $300.89M | 12 month · $8.14M | $293.92M | (m) | 12 month · $2.42M | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | $240.27M | 12 month · $10.75M | (m) | (m) | 12 month · $25.00K | 12 month · $-1.14M |
| 2008-12-31 | (m) | (m) | (m) | (m) | $202.06M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |